Clinical trials
Phase 2 Carcinoma, Medullary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 2 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| M.D. Anderson Cancer Center | 2 |
| Columbia University | 1 |
| Delcath Systems Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Kenneth Ain | 1 |
| Massachusetts General Hospital | 1 |
| NantCell, Inc. | 1 |
| Northwestern University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Medullary | 23 |
| Thyroid Neoplasms | 13 |
| Thyroid Cancer, Papillary | 9 |
| Adenocarcinoma, Follicular | 8 |
| Thyroid Carcinoma, Anaplastic | 6 |
| Head and Neck Neoplasms | 5 |
| Pheochromocytoma | 4 |
| Carcinoma, Hepatocellular | 3 |
| Pancreatic Neoplasms | 3 |
| Somatostatinoma | 3 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.